Saudi Arabia Alzheimers Disease Diagnostics Market Size & Outlook

The alzheimers disease diagnostics market in Saudi Arabia is expected to reach a projected revenue of US$ 158.3 million by 2033. A compound annual growth rate of 6.4% is expected of Saudi Arabia alzheimers disease diagnostics market from 2026 to 2033.
Revenue, 2025 (US$M)
$96.9
Forecast, 2033 (US$M)
$158.3
CAGR, 2026 - 2033
6.4%
Report Coverage
Saudi Arabia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Saudi Arabia alzheimers disease diagnostics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Saudi Arabia alzheimers disease diagnostics market highlights

  • The Saudi Arabia alzheimers disease diagnostics market generated a revenue of USD 96.9 million in 2025 and is expected to reach USD 158.3 million by 2033.
  • The Saudi Arabia market is expected to grow at a CAGR of 6.4% from 2026 to 2033.
  • In terms of segment, imaging techniques was the largest revenue generating diagnostic technique in 2025.
  • Biomarkers is the most lucrative diagnostic technique segment registering the fastest growth during the forecast period.


Alzheimers disease diagnostics market data book summary

Market revenue in 2025USD 96.9 million
Market revenue in 2033USD 158.3 million
Growth rate6.4% (CAGR from 2026 to 2033)
Largest segmentImaging techniques
Fastest growing segmentBiomarkers
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationBiomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests
Key market players worldwideQuest Diagnostics Inc, Sysmex Corp, Lantheus Holdings Inc, Siemens Healthineers AG ADR, F. Hoffmann-La Roche Ltd., Quanterix, Fujirebio Diagnostics, C2N Diagnostics


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 1.1% of the global alzheimers disease diagnostics market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia alzheimers disease diagnostics market is projected to lead the regional market in terms of revenue in 2033.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 125.5 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Alzheimers Disease Diagnostics Market Companies

Name Profile # Employees HQ Website
Quanterix View profile 251-500 Billerica, Massachusetts, United States, North America http://www.quanterix.com
Fujirebio Diagnostics View profile 5001-10000 Malvern, Pennsylvania, United States, North America http://www.fdi.com/
C2N Diagnostics View profile 11-50 Saint Louis, Missouri, United States, North America https://c2n.com/
F. Hoffmann-La Roche Ltd. View profile - - -
Lantheus Holdings Inc View profile 834 201 Burlington Road, South Building, Bedford, MA, United States, 01730 https://www.lantheus.com
Sysmex Corp View profile 10448 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 http://www.sysmex.co.jp
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com

Saudi Arabia alzheimers disease diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to alzheimers disease diagnostics market will help companies and investors design strategic landscapes.


Imaging techniques was the largest segment with a revenue share of 42.93% in 2025. Horizon Databook has segmented the Saudi Arabia alzheimers disease diagnostics market based on biomarkers, imaging techniques, genetic testing, cognitive assessment tests covering the revenue growth of each sub-segment from 2021 to 2033.


The Alzheimer’s disease diagnostics market in Saudi Arabia is influenced by several factors such as rising government initiatives and fundings, increasing healthcare infrastructure, and rising aging population. 

The Saudi government has been investing heavily in modernizing the country's healthcare infrastructure, including the establishment of advanced diagnostic facilities and specialized centers for neurological disorders. 

For instance, according to an article published by the International Trade Administration, in January 2024, Under Vision 2030, the Saudi government plans to invest over $65 billion to develop the country's healthcare system, reorganize and market health and insurance services, create 21 "health clusters" across the country, and expand access to ehealth services. 

Reasons to subscribe to Saudi Arabia alzheimers disease diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia alzheimers disease diagnostics market databook

  • Our clientele includes a mix of alzheimers disease diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia alzheimers disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia alzheimers disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia alzheimers disease diagnostics market size, by diagnostic technique, 2021-2033 (US$M)

Saudi Arabia Alzheimers Disease Diagnostics Market Outlook Share, 2025 & 2033 (US$M)

Saudi Arabia alzheimers disease diagnostics market size, by diagnostic technique, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online